KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Aug 06, 2025 >>  ABB India 5098.05  [ 0.27% ]  ACC 1830.6  [ 1.55% ]  Ambuja Cements 589.7  [ -2.16% ]  Asian Paints Ltd. 2491.3  [ 2.19% ]  Axis Bank Ltd. 1070.7  [ 0.01% ]  Bajaj Auto 8177.05  [ -0.64% ]  Bank of Baroda 241.75  [ 0.46% ]  Bharti Airtel 1929.65  [ -0.01% ]  Bharat Heavy Ele 239.65  [ -3.39% ]  Bharat Petroleum 315.85  [ 0.25% ]  Britannia Ind. 5395.4  [ -4.19% ]  Cipla 1487.1  [ -0.81% ]  Coal India 377  [ -0.68% ]  Colgate Palm. 2241.05  [ 0.41% ]  Dabur India 514  [ -2.10% ]  DLF Ltd. 765.25  [ -1.98% ]  Dr. Reddy's Labs 1197.1  [ -1.38% ]  GAIL (India) 169.95  [ -0.82% ]  Grasim Inds. 2766.85  [ -1.06% ]  HCL Technologies 1461.9  [ -1.38% ]  HDFC Bank 1983  [ 0.32% ]  Hero MotoCorp 4474.5  [ -1.49% ]  Hindustan Unilever L 2533.8  [ -0.07% ]  Hindalco Indus. 685  [ -0.24% ]  ICICI Bank 1444.75  [ 0.03% ]  Indian Hotels Co 746.6  [ -0.63% ]  IndusInd Bank 803.15  [ -1.96% ]  Infosys L 1435.75  [ -1.64% ]  ITC Ltd. 412  [ -0.50% ]  Jindal St & Pwr 986.5  [ -1.31% ]  Kotak Mahindra Bank 2002.15  [ -0.04% ]  L&T 3629.25  [ -0.59% ]  Lupin Ltd. 1851.6  [ -0.63% ]  Mahi. & Mahi 3228  [ 0.55% ]  Maruti Suzuki India 12525.15  [ 0.01% ]  MTNL 44.29  [ -2.40% ]  Nestle India 2233.3  [ -1.49% ]  NIIT Ltd. 118.5  [ -2.31% ]  NMDC Ltd. 71.86  [ -0.11% ]  NTPC 332.3  [ -0.36% ]  ONGC 233.85  [ -0.28% ]  Punj. NationlBak 103.85  [ 0.19% ]  Power Grid Corpo 284.8  [ -0.40% ]  Reliance Inds. 1392.95  [ 0.10% ]  SBI 805.15  [ 0.56% ]  Vedanta 440.65  [ 0.50% ]  Shipping Corpn. 209.4  [ -0.48% ]  Sun Pharma. 1594.1  [ -2.33% ]  Tata Chemicals 949.6  [ -1.51% ]  Tata Consumer Produc 1053.05  [ -1.02% ]  Tata Motors 653.05  [ -0.24% ]  Tata Steel 158.7  [ -0.56% ]  Tata Power Co. 385.7  [ 0.10% ]  Tata Consultancy 3031.6  [ -1.00% ]  Tech Mahindra 1459.4  [ -1.74% ]  UltraTech Cement 12225.45  [ -0.58% ]  United Spirits 1306.35  [ -1.33% ]  Wipro 240  [ -2.40% ]  Zee Entertainment En 112.3  [ -3.81% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

JAGSONPAL PHARMACEUTICALS LTD.

06 August 2025 | 12:00

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE048B01035 BSE Code / NSE Code 507789 / JAGSNPHARM Book Value (Rs.) 29.62 Face Value 2.00
Bookclosure 12/09/2025 52Week High 328 EPS 8.32 P/E 32.37
Market Cap. 1792.27 Cr. 52Week Low 140 P/BV / Div Yield (%) 9.09 / 0.93 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
1995 - The Company is well poised to venture into new areas of activity which will propel it into achieving its projected goals.

1998 - The company is all set to realise it's laid-out expansion plans and gain substantially, both in sales volume and profits, with its proposed new product introductions, in the year.

1999 - The Company launched/re-launched a few products, which have been well received in the market.

- The Company raised funds to the tune of Rs.5 crores through issue of 5,00,000 16% Non-Convertible Secured Debentures of Rs. 100 each to Life Insurance Corporation of India, General Insurance Corporation of India (GIC) and four subsidiaries of GIC.

- The company is manufacturing off-patent drugs, where the entry barriers are relatively low.

- The company has entered into tie-ups to make a range of anti-oxidants and hormones which are expected to be launched in 1999-2000.

2000 - The Company is having in-house share transfer and related facilities at the Registered office New Delhi. The Company is entering into an agreement with NSDL and CDSL for dematerialisation.

2004 -Company has issued a bonus shares in the ratio of 3:1.

2011 -The company has recommended a dividend of Rs. 0.50 per equity shares. 2013 -The company has recommended a dividend of Rs. 0.50 per equity shares. -Mr. Raj Kumar Kapoor has been appointed as Compliance officer cum Company Secretary of the company.

2014 -The company has recommended dividend of Rs. 0.50/- per Equity share.

2024 -The Company has informed regarding Acquisition for signing Business Transfer Agreement for the purchase of India & Bhutan business of Yash Pharma Laboratories Pvt.Ltd. -The Company Launches MemUp India's First Bioidentical Hormone Replacement Therapy in a Single Pill.